4//SEC Filing
Nunes Anne 4
Accession 0001171843-24-001459
CIK 0000898437other
Filed
Mar 18, 8:00 PM ET
Accepted
Mar 19, 5:17 PM ET
Size
8.1 KB
Accession
0001171843-24-001459
Insider Transaction Report
Form 4
Nunes Anne
SVP, Chief Operations Officer
Transactions
- Award
Restricted Stock Unit
2024-03-15+10,912→ 10,912 totalExercise: $0.00→ Common Stock (10,912 underlying) - Award
Stock Option (Right to Buy)
2024-03-15+26,442→ 26,442 totalExercise: $27.98Exp: 2034-03-11→ Common Stock (26,442 underlying)
Footnotes (3)
- [F1]Each RSU represents the contingent right to receive, at the Company's discretion, one share of the Company's common stock, or the cash equivalent of the closing price of one share of the Company's common stock, on each vest date. The RSUs vest in three equal annual installments beginning March 15, 2025.
- [F2]Represents a 10% premium above the closing price of Anika's common stock on the date of grant.
- [F3]The premium priced stock options vest in three equal annual installments beginning on March 15, 2025.
Documents
Issuer
Anika Therapeutics, Inc.
CIK 0000898437
Entity typeother
Related Parties
1- filerCIK 0001982862
Filing Metadata
- Form type
- 4
- Filed
- Mar 18, 8:00 PM ET
- Accepted
- Mar 19, 5:17 PM ET
- Size
- 8.1 KB